# Citations for Research Query

**Query:** # Disease Pathophysiology Research Template

## Target Disease
- **Disease Name:** Lung Carcinoma
- **MONDO ID:**  (if available)
- **Category:** Cancer

## Research Objectives

Please provide a comprehensive research report on the pathophysiology of **Lung Carcinoma**.
Focus on the molecular and cellular mechanisms underlying disease progression.

### Required Information

#### 1. Core Pathophysiology
- What are the primary pathophysiological mechanisms?
- What molecular pathways are dysregulated?
- What cellular processes are affected?

#### 2. Key Molecular Players
- **Genes/Proteins**: Which genes are causally involved or implicated?
- **Chemical Entities**: What metabolites, drugs, or small molecules are relevant?
- **Cell Types**: Which cell types are primarily affected?
- **Anatomical Locations**: Which tissues/organs are involved?

#### 3. Biological Processes (for GO annotation)
- What biological processes (GO terms) are disrupted?
- Consider: signaling pathways, metabolic processes, cellular responses, transport, etc.

#### 4. Cellular Components
- Where in the cell do key processes occur?
- Consider: organelles, membrane compartments, extracellular space, etc.

#### 5. Disease Progression
- What is the sequence of events from initial trigger to clinical manifestation?
- Are there distinct stages or phases?

#### 6. Phenotypic Manifestations
- What are the key clinical phenotypes?
- How do they relate to the underlying mechanisms?

### Citation Requirements

- Cite primary literature (PMID preferred) for all mechanistic claims
- Prioritize recent reviews and landmark papers
- Include direct quotes where possible to support key statements

### Output Format

Structure your response as a narrative that could be used to populate a disease knowledge base entry with:
- Pathophysiology description
- Gene/protein annotations with ontology terms (HGNC, GO)
- Phenotype associations (HP terms)
- Cell type involvement (CL terms)
- Anatomical locations (UBERON terms)
- Chemical entities (CHEBI terms)
- Evidence items with PMIDs

**Provider:** perplexity
**Generated:** 2026-02-01T09:32:27.178332

1. https://pmc.ncbi.nlm.nih.gov/articles/PMC2852571/
2. https://pmc.ncbi.nlm.nih.gov/articles/PMC12557266/
3. https://pmc.ncbi.nlm.nih.gov/articles/PMC12170712/
4. https://tlcr.amegroups.org/article/view/104086/html
5. https://geneglobe.qiagen.com/us/knowledge/pathways/non-small-cell-lung-cancer-signaling
6. https://pmc.ncbi.nlm.nih.gov/articles/PMC8909869/
7. https://www.lung.org/lung-health-diseases/lung-disease-lookup/lung-cancer/basics/lung-cancer-types
8. https://pubmed.ncbi.nlm.nih.gov/40244052/
9. https://pubmed.ncbi.nlm.nih.gov/26542886/
10. https://www.cancer.org/cancer/types/lung-cancer/about/what-is.html
11. https://elifesciences.org/reviewed-preprints/101885v1/pdf
12. https://www.explorationpub.com/Journals/em/Article/1001327
13. https://pmc.ncbi.nlm.nih.gov/articles/PMC4715592/
14. https://physicianresources.dana-farber.org/news/new-strategy-for-small-cell-lung-cancer-treatment-emerges-from-dana-farber-science
15. https://pmc.ncbi.nlm.nih.gov/articles/PMC2760965/
16. https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2024.1379698/full
17. https://pmc.ncbi.nlm.nih.gov/articles/PMC12820914/
18. https://www.frontiersin.org/journals/molecular-biosciences/articles/10.3389/fmolb.2021.731788/full
19. https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1549276/full
20. https://pmc.ncbi.nlm.nih.gov/articles/PMC3479369/
21. https://pmc.ncbi.nlm.nih.gov/articles/PMC8850794/
22. https://pmc.ncbi.nlm.nih.gov/articles/PMC4573780/
23. https://aacrjournals.org/cancerres/article/61/17/6367/507747/Smoking-Increases-Carcinogenic-Polycyclic-Aromatic
24. https://pmc.ncbi.nlm.nih.gov/articles/PMC2952281/
25. https://pmc.ncbi.nlm.nih.gov/articles/PMC11763869/
26. https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.951817/full
27. https://pmc.ncbi.nlm.nih.gov/articles/PMC7516130/
28. https://pmc.ncbi.nlm.nih.gov/articles/PMC4972690/
29. https://pubmed.ncbi.nlm.nih.gov/40960909/
30. https://www.atsjournals.org/doi/10.1165/rcmb.2023-0176PS
31. https://pmc.ncbi.nlm.nih.gov/articles/PMC8798790/
32. https://pmc.ncbi.nlm.nih.gov/articles/PMC2864581/
33. https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.757323/full
34. https://www.cancer-genetics.org/EML4.htm
35. https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2022.873994/full
36. https://pmc.ncbi.nlm.nih.gov/articles/PMC12016192/
37. https://pmc.ncbi.nlm.nih.gov/articles/PMC12479462/
38. https://pmc.ncbi.nlm.nih.gov/articles/PMC2852566/
39. https://pmc.ncbi.nlm.nih.gov/articles/PMC6341993/
40. https://www.sigmaaldrich.com/DE/de/technical-documents/technical-article/protein-biology/protein-expression/nf-b-and-inflammation
41. https://thoracickey.com/genomic-alterations-in-lung-cancer/
42. https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2021.648407/epub
43. https://pmc.ncbi.nlm.nih.gov/articles/PMC5312474/
44. https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2013.00135/full
45. https://www.pnas.org/doi/10.1073/pnas.0907781106
46. https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.672195/full
47. https://www.pnas.org/doi/10.1073/pnas.0701059104
48. https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2025.1542967/full
49. https://pmc.ncbi.nlm.nih.gov/articles/PMC3787909/
50. https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2023.1250893/full
51. https://pmc.ncbi.nlm.nih.gov/articles/PMC5404364/
52. https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0248798
53. https://pmc.ncbi.nlm.nih.gov/articles/PMC11170811/
54. https://www.cancer.org/cancer/types/lung-cancer/treating-non-small-cell/targeted-therapies.html
55. https://pmc.ncbi.nlm.nih.gov/articles/PMC12584817/
56. https://pmc.ncbi.nlm.nih.gov/articles/PMC3875680/
57. https://pmc.ncbi.nlm.nih.gov/articles/PMC4084653/
58. https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1679537/full
59. https://www.aging-us.com/article/204543/text
60. https://pmc.ncbi.nlm.nih.gov/articles/PMC4580090/
61. multi-omics studies of patient samples[3]
62. one study[1]
63. local signals[55]